Early Alzheimer’s, cancer research paper mills and treatment access | Health Wrap 56

Early Alzheimer’s, cancer research paper mills and treatment access | Health Wrap 56 left https://th-i.thgim.com/public/videos/xa11aa/article71622596.ece/alternates/FREE_1200/health%20wrap-%20ebola%202.png m9b6my2p Early Alzheimer's, cancer research paper mills and treatment access | Health Wrap 56 Early Alzheimer's, cancer research paper mills and treatment access | Health Wrap 56 The Hindu 699 16:9 In the 56th episode of Health Wrap by The Hindu, Ramya Kannan, Health Editor, The Hindu, and Zubeda Hamid, Senior Assistant Editor, The Hindu, discuss health issues that highlight the importance of early diagnosis, reliable scientific evidence and access to treatment.

The episode looks at how early-onset Alzheimer’s disease can present differently in people below the age of 65, with symptoms affecting language, vision and other thinking abilities, sometimes making diagnosis more challenging.

It also examines concerns over more than 4,000 cancer research papers flagged for suspected links to paper mills, businesses that produce and sell research papers, sometimes using fabricated data or manipulated findings.

The discussion explains why such concerns matter for the reliability of scientific evidence, while noting that flagged papers require further investigation.

The episode also looks at concerns raised by families of children living with spinal muscular atrophy (SMA) in Keralam over a generic drug.

With SMA affecting the nerve cells that control muscle movement, treatment and ongoing care can be crucial.

Families need clear information about the safety, effectiveness and quality of medicines, alongside affordable and accessible treatment options for this rare genetic condition.